or
forgot password

Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel MRI, FDG-PET, and Histopathologic Correlation


N/A
18 Years
N/A
Not Enrolling
Both
Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers

Thank you

Trial Information

Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel MRI, FDG-PET, and Histopathologic Correlation


Inclusion Criteria:

- Adult patients with newly diagnosed (biopsy-proven), untreated
squamous cell carcinoma (SCC) of the head and neck who will undergo neck dissection as
part of primary surgical therapy.

Exclusion Criteria:- A prior adverse reaction to the contrast/tracer agents being used in
the imaging methods being studied.

- Pregnancy.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To evaluate the performance of novel imaging methods for detecting cervical nodal metastasis.

Outcome Time Frame:

pre and post surgery

Safety Issue:

No

Principal Investigator

Dr. Billy W. Loo Jr. M.D. Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

ENT0011

NCT ID:

NCT00313027

Start Date:

November 2002

Completion Date:

March 2005

Related Keywords:

  • Head and Neck Cancer
  • Carcinoma, Squamous Cell
  • Head and Neck Cancers
  • Carcinoma
  • Carcinoma, Squamous Cell
  • Head and Neck Neoplasms

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317